Long-term Follow-up of Huntington's Disease Patients Treated With Intrastriatal Fetal Neuron Allograft
Long-term Follow-up of Huntington's Disease Patients Treated With Intrastriatal Fetal Neuron Allograft
Long-term follow-up of Huntington's disease patients treated with intrastriatal allografts is essential to assess the benefit/risk ratio of grafts as well as their effectiveness. Indeed, some patients are likely to develop adverse effects and the impact of alloimmunisation phenomena remains to be explored.
The aim is to create a specific cohort of transplant patients, to homogenise their follow-up methods, to collect all the patient data (medical, paramedical, imaging, biological) acquired from the end of their participation in MIG-HD'study (Foetal Striatal allografting in Huntington's disease: a multicentre, randomised, delayed start, phase 2 open-label cell therapy trial) until the last possible follow-up of the last patient in the study
Inclusion Criteria:
Exclusion Criteria:
anne-catherine.bachoud-levi@aphp.fr1 49 81 43 01 ext. +33